Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
| ▸ | TBXAS1 | P24557 | 8/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1278387 | 0.94 | CAPN1 (0.59) | CAPN1MAPTRXFP1HDAC3MAPK1 | |
| SCHEMBL608745 | 0.86 | CAPN1 (0.69) | CAPN1HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL7065645 | 0.78 | MAPT (0.79) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL20663547 | 0.77 | CAPN1 (0.45) | CAPN1SMN1; SMN2 | |
| SCHEMBL9671779 | 0.76 | MAPT (0.83) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL3814880 | 0.76 | MAPT (0.83) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| SCHEMBL7290858 | 0.75 | CAPN1 (0.48) | CAPN1MAPTRXFP1 | |
| SCHEMBL311759 | 0.74 | — | — | |
| SCHEMBL7827144 | 0.74 | MAPT (0.80) | MAPTRXFP1HDAC3MAPK1ADRA1A | |
| 5-Phenylvaleric Acid SCHEMBL503601 | 0.74 | MAPT (0.96) | MAPTRXFP1HDAC3MAPK1ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3391876-B1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | SDG INC (US) | 2021-03-10 | — | — | EP | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-8378058-B2 | Conducting polymers and uses thereof | AUCKLAND UNISERVICES LIMITED (NZ) | 2013-02-19 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2009-08-27 | — | — | US | disclosed |
| WO-2007018439-A1 | CONDUCTING POLYMERS AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215958-A1 | CONDUCTING POLYMERS AND USES THEREOF | PIN1, PPIA, PARG | CAPN1 1686/4885MAPT 821/4885RXFP1 4062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.